Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33190785)

  • 1. Fragmented Care in the Treatment of Rectal Cancer and Time to Definitive Therapy.
    Abelson JS; Bauer PS; Barron J; Bommireddy A; Chapman WC; Schad C; Ohman K; Hunt S; Mutch M; Silviera M
    J Am Coll Surg; 2021 Jan; 232(1):27-33. PubMed ID: 33190785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travel Time to a High Volume Center Negatively Impacts Timing of Care in Rectal Cancer.
    Abelson JS; Barron J; Bauer PS; Chapman WC; Schad C; Ohman K; Glasgow S; Hunt S; Mutch M; Smith RK; Wise PE; Silviera M
    J Surg Res; 2021 Oct; 266():96-103. PubMed ID: 33989893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.
    Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA
    Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could meeting the standards of the National Accreditation Program for Rectal Cancer in the National Cancer Database improve patient outcomes?
    Brady JT; Bingmer K; Bliggenstorfer J; Xu Z; Fleming FJ; Remzi FH; Monson JRT; Wexner SD; Dietz DW;
    Colorectal Dis; 2023 May; 25(5):916-922. PubMed ID: 36727838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer.
    Brady JT; Xu Z; Scarberry KB; Saad A; Fleming FJ; Remzi FH; Wexner SD; Winchester DP; Monson JRT; Lee L; Dietz DW;
    J Am Coll Surg; 2018 May; 226(5):881-890. PubMed ID: 29580675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Incomplete Neoadjuvant Radiotherapy and Survival for Patients With Locally Advanced Rectal Cancer.
    Freischlag K; Sun Z; Adam MA; Kim J; Palta M; Czito BG; Migaly J; Mantyh CR
    JAMA Surg; 2017 Jun; 152(6):558-564. PubMed ID: 28273303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
    Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
    Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
    Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
    Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
    Crane CH; Skibber JM; Birnbaum EH; Feig BW; Singh AK; Delclos ME; Lin EH; Fleshman JW; Thames HD; Kodner IJ; Lockett MA; Picus J; Phan T; Chandra A; Janjan NA; Read TE; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):84-9. PubMed ID: 12909219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of multidisciplinary therapy in node-positive rectal cancer.
    Roos M; Wong JH; Roy-Chowdhury S; Lum SS; Morgan JW; Kazanjian AK
    Am Surg; 2010 Oct; 76(10):1163-6. PubMed ID: 21105635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Fragmentation of Care in Locally Advanced Rectal Cancer Increase Patient Mortality?
    Freischlag K; Olivere L; Turner M; Adam M; Mantyh C; Migaly J
    J Gastrointest Surg; 2021 May; 25(5):1287-1296. PubMed ID: 32754789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.
    Dobie SA; Warren JL; Matthews B; Schwartz D; Baldwin LM; Billingsley K
    Cancer; 2008 Feb; 112(4):789-99. PubMed ID: 18189291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.